Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Ethinyl estradiol; norethindrone - Generic Drug Details

« Back to Dashboard

What are the generic sources for ethinyl estradiol; norethindrone and what is the scope of ethinyl estradiol; norethindrone freedom to operate?

Ethinyl estradiol; norethindrone
is the generic ingredient in one hundred and two branded drugs marketed by Ortho Mcneil Pharm, Novast Labs Ltd, Mylan Labs Ltd, Lupin Ltd, Vintage Pharms, Warner Chilcott Llc, Janssen Pharms, Watson Labs, Warner Chilcott, Glenmark Generics, Aurobindo Pharma Ltd, Vintage Pharms Llc, Barr, LPI, Allergan Sales Llc, Ortho Mcneil Janssen, Accord Hlthcare, Apil, Mayne Pharma, Watson Pharms Teva, Amneal Pharms, Barr Labs Inc, Parke Davis, Glenmark Pharms Ltd, and Lupin Atlantis, and is included in one hundred and twenty-five NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for ethinyl estradiol; norethindrone. Twenty-three suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: ethinyl estradiol; norethindrone

Tradenames:102
Patents:4
Applicants:25
NDAs:125
Drug Master File Entries: see list26
Suppliers / Packagers: see list23
Bulk Api Vendors: see list4
Clinical Trials: see list265
Patent Applications: see list16
Drug Prices:see low prices
DailyMed Link:ethinyl estradiol; norethindrone at DailyMed

Pharmacology for Ingredient: ethinyl estradiol; norethindrone

Tentative approvals for ETHINYL ESTRADIOL; NORETHINDRONE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe0.02MG;1MGTABLET, CHEWABLE;ORAL
► Subscribe► Subscribe0.01MG,0.01MG;1MG,N/ATABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma
TRI-NORINYL 28-DAY
ethinyl estradiol; norethindrone
TABLET;ORAL-28018977-002Apr 13, 1984ABRXYesYes► Subscribe► Subscribe
Mylan Labs Ltd
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
ethinyl estradiol; norethindrone acetate
TABLET;ORAL207259-001Dec 27, 2016ABRXNoNo► Subscribe► Subscribe
Vintage Pharms Llc
GILDESS FE 1.5/30
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-28077075-001Apr 28, 2005ABRXNoNo► Subscribe► Subscribe
Vintage Pharms Llc
GILDESS 1/20
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21077077-002Jul 24, 2012ABRXNoNo► Subscribe► Subscribe
Mylan Labs Ltd
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ethinyl estradiol; norethindrone
TABLET, CHEWABLE;ORAL203371-001Apr 23, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot